• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FK506 可改善亨廷顿病纹状体细胞模型中的细胞死亡特征。

FK506 ameliorates cell death features in Huntington's disease striatal cell models.

机构信息

Center for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.

出版信息

Neurochem Int. 2011 Oct;59(5):600-9. doi: 10.1016/j.neuint.2011.04.009. Epub 2011 Jun 15.

DOI:10.1016/j.neuint.2011.04.009
PMID:21703318
Abstract

Huntington's disease (HD) is a genetic neurodegenerative disorder characterized by striatal neurodegeneration, involving apoptosis. FK506, an inhibitor of calcineurin (or protein phosphatase 3, formerly known as protein phosphatase 2B), has shown neuroprotective effects in several cellular and animal models of HD. In the present study, we show the protective effects of FK506 in two striatal HD models, primary rat striatal neurons treated with 3-nitropropionic acid (3-NP) and immortalized striatal STHdh cells derived from HD knock-in mice expressing normal (STHdh(7/7)) or full-length mutant huntingtin (FL-mHtt) with 111 glutamines (STHdh(111/111)), under basal conditions and after exposure to 3-NP or staurosporine (STS). In rat striatal neurons, FK506 abolished 3-NP-induced increase in caspase-3 activation, DNA fragmentation/condensation and necrosis. Nevertheless, in STHdh(111/111) cells under basal conditions, FK506 did not prevent, in a significant manner, the release of cytochrome c and apoptosis inducing factor (AIF) from mitochondria, or alter Bax/Bcl-2 ratio, but significantly reverted caspase-3 activation. In STHdh(111/111) cells treated with 0.3mM 3-NP or 25 nM STS, linked to high necrosis, exposure to FK506 exerted no significant effects on caspase-3 activation. However, treatment of STHdh(111/111) cells exposed to 10nM STS with FK506 effectively prevented cell death by apoptosis and moderate necrosis. The results suggest that FK506 may be neuroprotective against apoptosis and necrosis under mild cell death stimulus in the presence of FLmHtt.

摘要

亨廷顿病(HD)是一种遗传性神经退行性疾病,其特征是纹状体神经退行性变,涉及细胞凋亡。FK506 是钙调神经磷酸酶(或蛋白磷酸酶 3,以前称为蛋白磷酸酶 2B)的抑制剂,在几种 HD 的细胞和动物模型中显示出神经保护作用。在本研究中,我们在两种纹状体 HD 模型中显示了 FK506 的保护作用,即用 3-硝基丙酸(3-NP)处理的原代大鼠纹状体神经元和源自携带正常(STHdh(7/7))或全长突变亨廷顿蛋白(FL-mHtt)的 HD 基因敲入小鼠的永生化纹状体 STHdh 细胞,FL-mHtt 携带 111 个谷氨酰胺(STHdh(111/111)),在基础条件下以及暴露于 3-NP 或 staurosporine(STS)后。在大鼠纹状体神经元中,FK506 消除了 3-NP 诱导的 caspase-3 活化、DNA 片段化/浓缩和坏死的增加。然而,在基础条件下的 STHdh(111/111)细胞中,FK506 并没有显著阻止细胞色素 c 和凋亡诱导因子(AIF)从线粒体释放,也没有改变 Bax/Bcl-2 比值,但显著逆转了 caspase-3 的活化。在 STHdh(111/111)细胞中用 0.3mM 3-NP 或 25 nM STS 处理,与高坏死相关,暴露于 FK506 对 caspase-3 活化没有显著影响。然而,FK506 处理暴露于 10nM STS 的 STHdh(111/111)细胞可有效防止凋亡和中等坏死导致的细胞死亡。结果表明,在存在 FLmHtt 的情况下,FK506 可能对轻度细胞死亡刺激下的凋亡和坏死具有神经保护作用。

相似文献

1
FK506 ameliorates cell death features in Huntington's disease striatal cell models.FK506 可改善亨廷顿病纹状体细胞模型中的细胞死亡特征。
Neurochem Int. 2011 Oct;59(5):600-9. doi: 10.1016/j.neuint.2011.04.009. Epub 2011 Jun 15.
2
Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.亨廷顿舞蹈病转基因小鼠模型中对丙二酸酯诱导的纹状体细胞死亡的部分抗性取决于年龄和CAG重复长度。
J Neurochem. 2001 Aug;78(4):694-703. doi: 10.1046/j.1471-4159.2001.00482.x.
3
Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway.来自突变亨廷顿蛋白基因敲入小鼠的纹状体细胞通过非凋亡途径对线粒体复合物II抑制剂诱导的细胞死亡具有选择性易感性。
Hum Mol Genet. 2004 Apr 1;13(7):669-81. doi: 10.1093/hmg/ddh082. Epub 2004 Feb 12.
4
Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington's disease knock-in striatal cell line.Bim表达增加有助于亨廷顿病基因敲入纹状体细胞系中血清剥夺诱导的凋亡性细胞死亡的增强。
Neurol Res. 2009 Feb;31(1):77-83. doi: 10.1179/174313208X331572. Epub 2008 Aug 7.
5
Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells.钙调神经磷酸酶参与突变亨廷顿蛋白基因敲入纹状体细胞中NMDA介导的细胞死亡的早期激活过程。
J Neurochem. 2008 Jun;105(5):1596-612. doi: 10.1111/j.1471-4159.2008.05252.x. Epub 2008 Jan 24.
6
Activation of Elk-1 participates as a neuroprotective compensatory mechanism in models of Huntington's disease.Elk-1 的激活作为一种神经保护的代偿机制参与亨廷顿病模型。
J Neurochem. 2012 May;121(4):639-48. doi: 10.1111/j.1471-4159.2012.07711.x. Epub 2012 Mar 28.
7
Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease.钙蛋白酶是3-硝基丙酸在体内诱导的选择性纹状体变性中的主要细胞死亡效应因子:对亨廷顿舞蹈症的意义。
J Neurosci. 2003 Jun 15;23(12):5020-30. doi: 10.1523/JNEUROSCI.23-12-05020.2003.
8
Mitochondrial-dependent apoptosis in Huntington's disease human cybrids.亨廷顿病人类杂种细胞中线粒体依赖性细胞凋亡。
Exp Neurol. 2010 Apr;222(2):243-55. doi: 10.1016/j.expneurol.2010.01.002. Epub 2010 Jan 14.
9
Astrocytes from cortex and striatum show differential responses to mitochondrial toxin and BDNF: implications for protection of striatal neurons expressing mutant huntingtin.来自皮质和纹状体的星形胶质细胞对线粒体毒素和脑源性神经营养因子表现出不同反应:对表达突变亨廷顿蛋白的纹状体神经元保护作用的启示。
J Neuroinflammation. 2020 Oct 6;17(1):290. doi: 10.1186/s12974-020-01965-4.
10
Glutathione redox cycle dysregulation in Huntington's disease knock-in striatal cells.亨廷顿病基因突变纹状体细胞中谷胱甘肽氧化还原循环失调。
Free Radic Biol Med. 2012 Nov 15;53(10):1857-67. doi: 10.1016/j.freeradbiomed.2012.09.004. Epub 2012 Sep 14.

引用本文的文献

1
Recent Advances in the Synthesis of Antioxidant Derivatives: Pharmacological Insights for Neurological Disorders.抗氧化衍生物合成的最新进展:神经紊乱的药理学研究。
Curr Top Med Chem. 2024;24(22):1940-1959. doi: 10.2174/0115680266305736240725052825.
2
Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington's disease.探讨亨廷顿病的分子机制、治疗策略和临床表现。
Arch Pharm Res. 2024 Jun;47(6):571-595. doi: 10.1007/s12272-024-01499-w. Epub 2024 May 19.
3
Cell Rearrangement and Oxidant/Antioxidant Imbalance in Huntington's Disease.
亨廷顿舞蹈病中的细胞重排与氧化/抗氧化失衡
Antioxidants (Basel). 2023 Feb 24;12(3):571. doi: 10.3390/antiox12030571.
4
Systematic Review of the Therapeutic Role of Apoptotic Inhibitors in Neurodegeneration and Their Potential Use in Schizophrenia.凋亡抑制剂在神经退行性变中的治疗作用及其在精神分裂症中的潜在应用的系统评价
Antioxidants (Basel). 2022 Nov 17;11(11):2275. doi: 10.3390/antiox11112275.
5
Analysis of Mitochondrial Dysfunction by Microplate Reader in hiPSC-Derived Neuronal Cell Models of Neurodegenerative Disorders.通过微板读数仪分析神经退行性疾病的 hiPSC 衍生神经元细胞模型中的线粒体功能障碍。
Methods Mol Biol. 2022;2549:1-21. doi: 10.1007/7651_2021_451.
6
Effect of tacrolimus on the expression of Park7 in glomerular podocytes injured by puromycin aminonucleoside.他克莫司对嘌呤霉素氨基核苷诱导的肾小球脏层上皮细胞 Park7 表达的影响。
Zhongguo Dang Dai Er Ke Za Zhi. 2021;23(9):951-958. doi: 10.7499/j.issn.1008-8830.2106061.
7
New Avenues for the Treatment of Huntington's Disease.治疗亨廷顿病的新途径。
Int J Mol Sci. 2021 Aug 4;22(16):8363. doi: 10.3390/ijms22168363.
8
Serine/Threonine Phosphatases in LTP: Two B or Not to Be the Protein Synthesis Blocker-Induced Impairment of Early Phase.丝氨酸/苏氨酸磷酸酶在 LTP 中的作用:二选一还是二选二——蛋白合成抑制剂诱导早期相受损
Int J Mol Sci. 2021 May 4;22(9):4857. doi: 10.3390/ijms22094857.
9
A novel Huntington's disease mouse model to assess the role of neuroinflammation on disease progression and to develop human cell therapies.一种新型亨廷顿舞蹈病小鼠模型,用于评估神经炎症对疾病进展的作用,并开发人类细胞疗法。
Stem Cells Transl Med. 2021 Jul;10(7):1033-1043. doi: 10.1002/sctm.20-0431. Epub 2021 Mar 12.
10
Neonatal Rotenone Administration Induces Psychiatric Disorder-Like Behavior and Changes in Mitochondrial Biogenesis and Synaptic Proteins in Adulthood.新生 Rotenone 处理诱导成年期精神障碍样行为和线粒体生物发生及突触蛋白的变化。
Mol Neurobiol. 2021 Jul;58(7):3015-3030. doi: 10.1007/s12035-021-02317-w. Epub 2021 Feb 19.